Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Prenetics Global Limited

Market Cap 345M 301M 279M 261M 489M 32.55B 492M 3.3B 1.28B 16.02B 1.29B 1.27B 55.63B P/E 2026 *
-9.51x
P/E 2027 * -37.5x
Enterprise Value 345M 301M 279M 261M 489M 32.55B 492M 3.3B 1.28B 16.02B 1.29B 1.27B 55.63B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.09x
Free-Float
85.39%
Yield 2026 *
-
Yield 2027 * -
1 day+3.25%
1 week-5.22%
Current month-2.84%
1 month+28.77%
3 months+4.49%
6 months+17.28%
Current year+30.16%
1 week 19.3
Extreme 19.3
21.2
1 month 16.8
Extreme 16.8
22.22
Current year 14
Extreme 14
23.63
1 year 7.18
Extreme 7.175
23.63
3 years 2.85
Extreme 2.85
23.63
5 years 2.85
Extreme 2.85
131.25
10 years 2.85
Extreme 2.85
131.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 52 31/12/2013
Chief Executive Officer 47 31/12/2013
Director of Finance/CFO 41 31/12/2017
Director TitleAgeSince
Director/Board Member 60 12/06/2024
Chairman 47 31/12/2013
Director/Board Member - 15/02/2026
Date Insider Type Main position Quantity % Market Cap.
06-14Fiscal year

Director

31,746 0.2082%
06-14Fiscal year

Director

15,625 0.1025%
06-03Other

Director

24,004 0.1574%
Change 5-day change 1-year change 3-year change Capi.($)
+3.25%-5.22%+128.79%+66.26% 345M
-0.10%+0.26%-33.52%-16.79% 154B
+1.54%-1.07%-8.11%-10.17% 102B
-0.99%+1.30%+58.58%+58.49% 56.51B
-1.90%-3.49%-7.43%+46.28% 52.89B
+1.67%-1.55%-14.51%-44.04% 39.67B
-1.32%-1.83% - - 30.39B
+1.74%-3.85%-9.41%-43.32% 27.96B
+1.35%-0.26%+51.96%-11.10% 23.17B
+0.90%+0.34%-16.09%-3.59% 20.35B
Average +0.61%-1.26%+16.69%+4.67% 50.68B
Weighted average by Cap. +0.22%-1.24%-6.27%-2.37%

Financials

2026 *2027 *
Net sales 201M 176M 163M 152M 286M 19.01B 287M 1.93B 748M 9.35B 756M 740M 32.48B 317M 276M 256M 239M 449M 29.87B 452M 3.03B 1.18B 14.7B 1.19B 1.16B 51.05B
Net income -51.05M -44.51M -41.22M -38.59M -72.37M -4.82B -72.81M -489M -190M -2.37B -192M -188M -8.23B -8.96M -7.81M -7.24M -6.77M -12.7M -845M -12.78M -85.84M -33.27M -416M -33.63M -32.91M -1.45B
Net Debt - -
Logo Prenetics Global Limited
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Employees
98
Date Price Change Volume
18/06/26 20.50 $ +3.25% 140,303
17/06/26 19.86 $ -3.19% 148,894
16/06/26 20.51 $ -1.16% 119,227
15/06/26 20.75 $ -4.07% 128,878
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
20.50USD
Average target price
31.00USD
Spread / Average Target
+51.22%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!